sinc
late
decemb
outbreak
novel
coronaviru
diseas
began
wuhan
becom
endem
china
countri
region
world
far
rare
data
preval
patient
chronic
myelogen
leukemia
cml
aim
describ
clinic
cours
outcom
cml
patient
preval
cml
patient
multicentr
crosssect
survey
clinic
data
cml
patient
center
collect
simultan
onlin
survey
conduct
inform
cml
patient
manag
center
ask
cml
patient
complet
questionnair
februari
februari
questionnair
includ
demograph
data
place
resid
smoke
statu
cml
diagnosi
treatment
comorbid
combin
medic
epidemiolog
histori
symptom
fever
cough
short
breath
etc
epidem
addit
clinic
data
collect
respond
suspect
confirm
describ
analyz
preval
cml
patient
focu
clinic
characterist
outcom
patient
data
compar
cml
patient
optim
respons
nonoptim
respons
primari
outcom
preval
cml
patient
feb
secondari
outcom
includ
histori
epidemiolog
cml
patient
clinic
characterist
outcom
cml
patient
respond
male
year
younger
patient
took
drug
irregularli
due
influenc
epidem
traffic
control
pharmaci
unabl
oper
normal
etc
histori
epidemiolog
patient
definit
contact
remot
contact
close
contact
respond
fever
cough
short
breath
epidem
case
sinc
late
decemb
outbreak
novel
coronaviru
diseas
wuhan
china
endem
china
countri
region
world
march
china
report
total
confirm
case
novel
coronaviru
diseas
death
hubei
provinc
still
core
area
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
februari
februari
clinic
data
cml
patient
center
collect
simultan
onlin
survey
conduct
inform
cml
patient
manag
center
ask
cml
patient
complet
questionnair
total
questionnair
collect
valid
exclud
respond
live
hubei
provinc
outbreak
questionnair
ask
gener
demograph
characterist
place
resid
smoke
statu
cml
diagnosi
treatment
comorbid
combin
medic
epidemiolog
histori
symptom
fever
cough
short
breath
etc
epidem
addit
clinic
data
collect
respond
suspect
confirm
miss
uncertain
record
collect
clarifi
direct
commun
involv
healthcar
provid
famili
primari
outcom
preval
cml
patient
feb
secondari
outcom
includ
histori
epidemiolog
cml
patient
clinic
characterist
outcom
cml
patient
aim
studi
report
preval
cml
patient
infect
cml
patient
differ
efficaci
compar
also
report
clinic
cours
clinic
outcom
patient
therefor
formal
hypothes
implement
drive
sampl
size
calcul
includ
maximum
number
patient
met
inclus
criteria
total
questionnair
collect
valid
among
questionnair
exclud
respond
live
hubei
provinc
outbreak
follow
gener
situat
respond
male
account
respond
year
younger
age
distribut
chart
shown
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
survey
found
respond
fever
cough
short
breath
epidem
period
go
hospit
symptom
mild
remit
oral
medic
three
peopl
went
hospit
treatment
chest
ct
scan
quantit
rtpcr
test
one
three
patient
confirm
take
imatinib
regularli
due
side
effect
efficaci
evalu
failur
regular
dose
reduct
imatinib
per
day
start
latest
bcrabl
fusion
gene
quantifi
decemb
earli
februari
initi
cough
quickli
develop
dyspnea
reliev
oxygen
therapi
home
admit
emerg
depart
found
extrem
lymphocytopenia
respiratori
failur
renal
insuffici
myocardi
damag
condit
rapidli
deterior
succumb
three
day
hospit
consist
previou
report
elderli
patient
comorbid
poor
prognosi
high
mortal
degre
lymphopenia
relat
sever
diseas
although
obtain
optim
respons
take
tki
outbreak
due
side
effect
midfebruari
present
cough
fever
found
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
infect
chest
ct
scan
show
pneumonia
cure
discharg
treatment
specif
data
clinic
diagnosi
confirm
patient
shown
tabl
year
old
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
antitumor
drug
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
forgotten
take
medicin
past
week
ye
patient
took
drug
irregularli
due
influenc
epidem
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
cml
respond
requir
regular
referr
hospit
much
contact
patient
outbreak
mainli
due
govern
polici
prevent
control
analyz
infect
patient
base
respons
anticml
therapi
see
tabl
summari
hubei
anticanc
associ
chronic
myeloid
leukemia
standard
manag
collabor
group
conduct
onlin
consult
onlin
smart
hospit
onlin
cours
provid
inform
diagnosi
treatment
patient
epidem
organ
volunt
deliv
drug
cml
patient
home
sampl
size
studi
rel
small
expand
accur
compar
preval
infect
differ
group
nevertheless
find
suggest
standard
manag
obtain
best
clinic
respons
reduc
risk
infect
improv
prognosi
infect
cml
chronic
hematolog
tumor
comprehens
measur
taken
delay
reduc
risk
infect
restrict
patient
exposur
situat
possibl
transmiss
epidem
special
attent
focus
cml
patient
older
comorbid
whose
respons
cml
treatment
nonoptim
optim
respons
person
warn
failur
person
forgotten
take
medicin
past
week
contact
infect
person
comorbid
diagnos
tabl
data
compar
cml
patient
optim
respons
nonoptim
respons
